BETMIGA mirabegron 50 mg film-coated prolonged-release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

betmiga mirabegron 50 mg film-coated prolonged-release tablet blister pack

astellas pharma australia pty ltd - mirabegron, quantity: 50 mg - tablet, modified release - excipient ingredients: macrogol 2000000; macrogol 8000; purified water; butylated hydroxytoluene; hyprolose; magnesium stearate; hypromellose; iron oxide yellow - symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence in patients with overactive bladder (oab) syndrome.

BETMIGA mirabegron 25 mg film-coated prolonged-release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

betmiga mirabegron 25 mg film-coated prolonged-release tablet blister pack

astellas pharma australia pty ltd - mirabegron, quantity: 25 mg - tablet, modified release - excipient ingredients: butylated hydroxytoluene; magnesium stearate; hyprolose; purified water; macrogol 2000000; macrogol 8000; hypromellose; iron oxide yellow; iron oxide red - symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence in patients with overactive bladder (oab) syndrome.

PROGRAF 1 MG Israel - English - Ministry of Health

prograf 1 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 1 MG Israel - English - Ministry of Health

prograf 1 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 5 MG Israel - English - Ministry of Health

prograf 5 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 5 MG Israel - English - Ministry of Health

prograf 5 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 0.5 MG Israel - English - Ministry of Health

prograf 0.5 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 0.5 MG Israel - English - Ministry of Health

prograf 0.5 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Vesicare Tablet 10mg Singapore - English - HSA (Health Sciences Authority)

vesicare tablet 10mg

astellas pharma singapore pte. ltd. - solifenacin succinate - tablet, film coated - 10mg/tablet - solifenacin succinate 10 mg

Vesicare Tablet 5mg Singapore - English - HSA (Health Sciences Authority)

vesicare tablet 5mg

astellas pharma singapore pte. ltd. - solifenacin succinate - tablet, film coated - 5mg/tablet - solifenacin succinate 5 mg